3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Melanoma
3
Neoplasm Metastasis
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma
1
Glioma
1
Extensive Stage Small Cell Lung Carcinoma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Cisplatin
24
Paclitaxel
21
pembrolizumab
15
Radiotherapy
12
Fluorouracil
12
Carboplatin
12
Drug Therapy
11
tislelizumab
10
toripalimab
9
Irinotecan
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Radiation
5
Neoadjuvant Therapy
5
Leucovorin
5
lenvatinib
4
camrelizumab
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Docetaxel
4
130-nm albumin-bound paclitaxel
4
apatinib
3
Taxes
3
Itraconazole
3
Injections
3
Albumin-Bound Paclitaxel
3
spartalizumab
2
sintilimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
epacadostat
×
1 year
×
Clear all
No trials found.